- Report
- May 2025
- 199 Pages
Global
From €3139EUR$3,545USD£2,718GBP
€3487EUR$3,939USD£3,020GBP
- Report
- May 2025
- 150 Pages
Global
From €5268EUR$5,950USD£4,562GBP
- Report
- July 2025
- 354 Pages
Global
From €5179EUR$5,850USD£4,486GBP
- Report
- June 2025
- 185 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- June 2025
- 81 Pages
Global
From €3500EUR$4,235USD£3,137GBP
- Report
- May 2025
- 191 Pages
Global
From €3139EUR$3,545USD£2,718GBP
€3487EUR$3,939USD£3,020GBP
- Report
- July 2025
- 187 Pages
Global
From €5179EUR$5,850USD£4,486GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1107EUR$1,250USD£958GBP
- Report
- June 2025
- 150 Pages
Global
From €2390EUR$2,699USD£2,070GBP
- Report
- February 2024
- 126 Pages
Global
From €2647EUR$2,990USD£2,293GBP
- Report
- May 2024
- 129 Pages
Global
From €5754EUR$6,499USD£4,983GBP
- Report
- January 2022
- 108 Pages
Global
From €6640EUR$7,500USD£5,751GBP
- Report
- April 2023
- 110 Pages
Global
From €4205EUR$4,750USD£3,642GBP
- Report
- March 2021
- 130 Pages
Global
From €13276EUR$14,995USD£11,498GBP

The Intravenous Iron market is a segment of the Hematological Drugs market, which includes drugs used to treat anemia and other blood disorders. Intravenous Iron is a type of drug used to treat iron deficiency anemia, a condition in which the body does not have enough iron to produce healthy red blood cells. Intravenous Iron is administered directly into the bloodstream, allowing for a more rapid increase in iron levels than oral iron supplements.
Intravenous Iron is used in a variety of settings, including hospitals, clinics, and home care. It is often prescribed to patients who are unable to take oral iron supplements due to gastrointestinal issues or who require a more rapid increase in iron levels.
The Intravenous Iron market is highly competitive, with a number of companies offering products in this space. Some of the major players in the market include Vifor Pharma, Fresenius Kabi, American Regent, and B. Braun. Show Less Read more